Background: Recently, a new commercial test for specific IgE based on immunochromatography (Immfast Check J1®) has been developed. We previously reported on the use of this kit for tear fluid samples during spring. In this study, we compared the level of specific IgE in tear fluid among patients with seasonal allergic conjunctivitis during spring or autumn and control subjects. Methods: A nonrandomized, cross-sectional study was conducted in patients with moderate-to-severe allergic conjunctivitis occurring in spring (n = 56, spring group) or autumn (n = 52, autumn group), as well as in age- and sex-matched healthy control subjects (n = 50, control group). Levels of specific IgE for cedar pollen, cat epithelium and Dermatophagoides pteronyssinus were measured in tear fluid with the Immfast Check J1. Results: Specific IgE scores for cedar pollen and D. pteronyssinus were significantly higher in the spring and autumn groups than in the control group (p < 0.0001). In the autumn group, the highest detection rate for a specific allergen was 96.2% for D. pteronyssinus, followed by cedar pollen (86.5%) and cat epithelium (25.5%). In the spring group, the highest detection rate was 98.3% for cedar pollen, followed by D. pteronyssinus (51.7%) and cat epithelium (19.0%). Conclusions: These results suggest that both house dust mite allergen and outdoor allergens such as cedar pollen can be causes of allergic conjunctivitis during both spring and autumn in Japan. The Immfast Check J1 provides rapid measurement of specific IgE in tear fluid, which allows easy diagnosis of allergic conjunctivitis in an outpatient setting.

Keywords:
Allergic conjunctivitis, Immfast Check J1®, Immunochromatography, Tear, Specific IgE
1.
Mimura T, Amano S, Funatsu H, Yamagami S, Araie M, Kaji Y, Arimoto A, Ishida Y, Usui T, Okamoto S: Correlations between allergen-specific IgE serum levels in patients with allergic conjunctivitis in spring. Ocul Immunol Inflamm 2004;12:45–51.
2.
Mimura T, Yamagami S, Amano S, Funatsu H, Arimoto A, Usui T, Ono K, Araie M, Okamoto S: Allergens in Japanese patients with allergic conjunctivitis in autumn. Eye 2005;19:995–999.
3.
Ballow M, Mendelson L: Specific immunoglobulin E antibodies in tear secretions of patients with vernal conjunctivitis. J Allergy Clin Immunol 1980;66:112–118.
4.
Liotet S, Warnet VN, Arrata M: Lacrimal immunoglobulin E and allergic conjunctivitis. Ophthalmologica 1983;186:31–34.
5.
Nomura K, Takamura E: Tear IgE concentrations in allergic conjunctivitis. Eye 1998;12:296–298.
6.
Sirbikaite L, Ehlers N: The use of Lacrytest in ocular allergy. Acta Ophthalmol Scand 2007;85:117.
7.
Monzón S, Arrondo E, Bartra J, Torres F, Basagaña M, del Mar San Miguel M, Alonso R, Cisteró-Bahima A: Conjunctivitis and Total IgE in Lacrimal Fluid: Lacrytest Screening. J Allergy (Cairo) DOI: 10.1155/2009/518903.
8.
Inada N, Shoji J, Kato H, Kiely S, Mulyanto, Sawa M: Clinical evaluation of total IgE in tears of patients with allergic conjunctivitis disease using a novel application of the immunochromatography method. Allergol Int 2009;58:585–589.
9.
Mimura T, Usui T, Mori M, Funatsu H, Noma H, Aixinjueluo W, Yamamoto H, Amano S: Rapid immunochromatography of total tear IgE in allergic conjunctivitis with allerwatch. J Invest Allergol Clin Immunol, in press.
10.
Mimura T, Usui T, Mori M, Aixinjueluo W, Funatsu H, Noma H, Amano S: Immunochromatographic assay for measurement of total IgE in tears, nasal mucus, and saliva of patients with allergic rhinoconjunctivitis. J Asthma 2010;47:1153–1160.
11.
Mimura T, Usui T, Mori M, Funatsu H, Noma H, Yamamoto H, Aixinjueluo W, Amano S: Relationship between total tear and serum IgE in allergic conjunctivitis. Int Arch Allergy Immunol 2010;154:349–352.
12.
Mimura T, Usui T, Mori M, Funatsu H, Noma H, Yamamoto H, Aixinjueluo W, Amano S: Relation between total tear IgE and specific serum IgE in seasonal allergic conjunctivitis. Cornea 2011, E-pub ahead of print, in press.
13.
Ikeda A, Shoji J, Muromoto K, Inada N, Sawa M, Kawamura M: Measurement of allergen-specific IgE antibodies in tears of patients with allergic conjunctival disease by IMM-FAST CHECK J1. Japanese Ophthalmology 2006;48;1829–1836.
14.
Mimura T, Usui T, Mori M, Funatsu H, Noma H, Amano S: Rapid immunochromatographic measurement of specific tear IgE in moderate to severe cases of allergic conjunctivitis with immfast check J1 in the spring. Cornea 2010, E-pub ahead of print.
15.
Ben Ezra D: Guidelines on the diagnosis and treatment of conjunctivitis. Ocul Immunol Inflam 1994;2(suppl):17–26.
16.
Shoji J, Inada N, Sawa M: Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease. Allergol Int 2009;58:591–597.
17.
Ono T, Kawamura M, Arao S, Nariuchi H: A highly sensitive quantitative immunochromatography assay for antigen-specific IgE. J Immunol Methods 2003;272:211–218.
18.
OnoT, Sugiyama K, Kuroda T, Kawamura M, Arao S, Nariuchi H: A quantitative immunochromatography assay of whole blood samples for antigen-specific IgE-A new method for point of care testing for allergens. Allergol Int 2005;54:393–399.
19.
Fujishima H, Sahashi N, Shimazaki J, Tsubota K: Allergic conjunctivitis caused by sugi (Cryptomeria japonica D. Don) pollen out of season. Asian Pac J Allergy Immunol 1995;13:113–117.
20.
Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, Barletta B, Becker WM, Blaser K, Breiteneder H, Chapman M, Crameri R, Duchêne M, Ferreira F, Fiebig H, Hoffmann-Sommergruber K, King TP, Kleber-Janke T, Kurup VP, Lehrer SB, Lidholm J, Müller U, Pini C, Reese G, Scheiner O, Scheynius A, Shen HD, Spitzauer S, Suck R, Swoboda I, Thomas W, Tinghino R, Van Hage-Hamsten M, Virtanen T, Kraft D, Müller MW, Valenta R: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414–416.
21.
Avseenko NV, Morozova TY, Ataullakhanov FI, Morozov VN: Immunoassay with multicomponent protein microarrays fabricated by electrospray deposition. Anal Chem 2002;74:927–933.
22.
Suck R, Nandy A, Weber B, Stock M, Fiebig H, Cromwell O: Rapid method for arrayed investigation of IgE-reactivity profiles using natural and recombinant allergens. Allergy 2002;57:821–824.
23.
Jahn-Schmid B, Harwanegg C, Hiller R, Bohle B, Ebner C, Scheiner O, Mueller MW: Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy 2003;33:1443–1449.
24.
Lin J, Bardina L, Shreffler WG: Microarrayed allergen molecules for diagnostics of allergy. Methods Mol Biol 2009;524:259–272.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.